Buprenorphine transdermal patch

Details

Files

Generic Name:

Buprenorphine transdermal patch

Project Status:

Cancelled

Therapeutic Area:

Pain, persistent (moderate intensity)

Manufacturer:

Purdue Pharma

Call for patient/clinician input open:

October 19, 2010

Brand Name:

BuTrans

Project Line:

Reimbursement Review

Project Number:

SR0211-000

Call for patient/clinician input closed:

November 5, 2010

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Pain, persistent (moderate intensity)

Files

Submission Status Report View PDF

Last Updated : October 15, 2010